Skip to content

Drug interactions

Indacaterol-glycopyrronium + Ketoconazole

Severity: Minor

Indacaterol-glycopyrronium and Ketoconazole: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Ketoconazole inhibits CYP3A4 and P-glycoprotein, which raises systemic indacaterol exposure. The increase is modest at usual doses and was not considered to need adjustment, but beta-agonist adverse effects could be enhanced.

What this interaction means in plain words

Indacaterol-glycopyrronium and Ketoconazole have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Indacaterol-glycopyrronium belongs to Respiratory; Ketoconazole belongs to Anti Fungals.

Evidence level: Moderate

Why it happens

Inhibition of CYP3A4 and P-gp reduces indacaterol clearance.

What to do

No dose adjustment is generally needed at standard doses. Be aware of tremor, palpitations or tachycardia during coadministration.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Indacaterol-glycopyrronium and Ketoconazole, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Indacaterol-glycopyrronium with Ketoconazole?

MediHelp rates the interaction as minor. Indacaterol-glycopyrronium and Ketoconazole have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Ketoconazole inhibits CYP3A4 and P-glycoprotein, which raises systemic indacaterol exposure. The increase is modest at usual doses and was not considered to need adjustment, but beta-agonist adverse effects could be enhanced.

How serious is the interaction between Indacaterol-glycopyrronium and Ketoconazole?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No dose adjustment is generally needed at standard doses. Be aware of tremor, palpitations or tachycardia during coadministration.

What other medicines interact with Indacaterol-glycopyrronium?

MediHelp also lists interactions of Indacaterol-glycopyrronium with, for example, Amisulpride, Arformoterol, Arsenic trioxide. The full list is on the Indacaterol-glycopyrronium page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in